Y-Intercept (HK)’s Madrigal Pharmaceuticals MDGL Stock Holding History

Y-Intercept (HK)’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.99M	Buy	+5,560	New	+$2.85M	0.06%	477
2025 Q3	–	Sell	-1,415	Closed	-$428K	–	1846
2025 Q2	$428K	Buy	+1,415	New	+$422K	0.01%	1253
2024 Q4	–	Sell	-1,736	Closed	-$368K	–	1468
2024 Q3	$368K	Buy	+1,736	New	+$444K	0.02%	922
2024 Q1	–	Sell	-1,551	Closed	-$359K	–	1607
2023 Q4	$359K	Buy	+1,551	New	+$271K	0.03%	755
2023 Q1	–	Sell	-871	Closed	-$253K	–	1393
2022 Q4	$253K	Buy	+871	New	+$85.2K	0.04%	732

Other funds holding MDGL

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Kozak & Associates Highlands Ranch, Colorado $576M AUM 23.37% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return